This study identifies B3GALT2 as a promising diagnostic biomarker for GA and further reveals a novel TFAP2A/B3GALT2 axis that plays a critical protective role in GA by suppressing NLRP3 inflammasome-mediated pyroptosis. These findings provide new insights into GA pathogenesis and highlight potential therapeutic targets.
Han et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: